Wellington Management Group’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Wellington Management Group’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-55,163	Closed	-$990K	–	2426
2017 Q4	$990K	Sell	55,163 -23,701	-30%	-$292K	﹤0.01%	1912
2017 Q3	$931K	Hold	78,864	–	–	﹤0.01%	1902
2017 Q2	$828K	Hold	78,864	–	–	﹤0.01%	1926
2017 Q1	$868K	Buy	+78,864	New	+$915K	﹤0.01%	1956
2016 Q2	–	Sell	-174,505	Closed	-$1.91M	–	2235
2016 Q1	$1.91M	Sell	174,505 -19,931	-10%	-$252K	﹤0.01%	1622
2015 Q4	$3.36M	Buy	194,436 +48,205	+33%	+$864K	﹤0.01%	1488
2015 Q3	$2.91M	Buy	146,231 +8,210	+6%	+$188K	﹤0.01%	1516
2015 Q2	$2.27M	Buy	138,021 +10,900	+9%	+$189K	﹤0.01%	1640
2015 Q1	$1.98M	Buy	+127,121	New	+$1.97M	﹤0.01%	1699
2014 Q4	–	Sell	-11,952	Closed	-$78K	–	2294
2014 Q3	$78K	Hold	11,952	–	–	﹤0.01%	2147
2014 Q2	$83K	Sell	11,952 -31,600	-73%	-$223K	﹤0.01%	2138
2014 Q1	$311K	Buy	43,552 +349	+0.8%	+$2.99K	﹤0.01%	2060
2013 Q4	$406K	Sell	43,203 -456	-1%	-$3.25K	﹤0.01%	2030
2013 Q3	$272K	Buy	43,659 +959	+2%	+$5.99K	﹤0.01%	2088
2013 Q2	$281K	Buy	+42,700	New	+$339K	﹤0.01%	2042

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Wellington Management Group's SCMP Position: Q1 2018 in Review

Wellington Management Group sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 55,163 shares — an estimated $990K sold.

Wellington Management Group first reported a position in SCMP in Q2 2013 and held it in 15 quarters. The position peaked at $3.36M in Q4 2015. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Wellington Management Group reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Wellington Management Group sold 55,163 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $990K.
Wellington Management Group first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 15 quarters.
Wellington Management Group's Sucampo Pharmaceuticals, Inc. position peaked at $3.36M in Q4 2015.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Wellington Management Group's 13F filing for Q1 2018, filed 15 May 2018.